A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan–lysyl oxidase inhibitor PXS-6302 in mature scars

赖氨酰氧化酶 安慰剂 疤痕 耐受性 中止 医学 羟脯氨酸 细胞外基质 纤维化 伤口愈合 随机对照试验 队列 不利影响 组织谷氨酰胺转胺酶 皮肤病科 临床试验 内科学 外科 色素沉着 病变 萎缩 胃肠病学 软骨 他扎罗汀 胶原纤维 病理
作者
Natalie M. Morellini,Peijun Gong,Suzanne M. Rea,Helen E. Douglas,Phuoc Hao Ho,Barry Cense,Brendan F. Kennedy,Wolfgang Jarolimek,Brett Charlton,Alison D. Findlay,Joanna Leadbetter,Fiona Melanie Wood,Mark William Fear
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:17 (815): eadv2471-eadv2471 被引量:4
标识
DOI:10.1126/scitranslmed.adv2471
摘要

Skin scars remain a substantial clinical challenge because of their impact on appearance and psychological well-being. Lysyl oxidases catalyze collagen cross-linking, a key factor in scar development. Here, we report a randomized, double-blind, placebo-controlled phase 1 study to assess the safety and tolerability of PXS-6302, a topical pan–lysyl oxidase inhibitor, in treating mature scars (ACTRN12621001545853). Fifty participants were enrolled across two cohorts: Cohort 1 (open label, n = 8) applied PXS-6302 (2%) daily, and cohort 2 ( n = 42) was randomized 1:1 to apply PXS-6302 (2%) or placebo three times per week to a 10-square-centimeter area of scar for 3 months. No severe adverse events (AEs) were reported. Mild to moderate localized skin reactions were the only treatment-related AEs, leading to discontinuation by six participants. Treatment with PXS-6302 three times per week reduced lysyl oxidase activity by 66% and decreased hydroxyproline (a marker for collagen) and total protein concentrations in scar biopsies compared with placebo. Optical coherence tomography showed increased microvessel density and tissue attenuation [a marker of extracellular matrix (ECM) composition] at 3 months compared with the baseline, suggesting ECM remodeling toward unscarred skin architecture. No significant differences in Patient Observer Scar Assessment Scale (POSAS) scores were observed between groups after 90 days of treatment once baseline imbalances were accounted for. Together, these data showed that topical pan–lysyl oxidase inhibition was generally well tolerated and altered some measures of the ECM in mature scars, supporting the advancement of this treatment into phase 2 trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小旋风完成签到,获得积分10
刚刚
Ma发布了新的文献求助10
刚刚
DuMilk完成签到,获得积分10
刚刚
有魅力的雨梅完成签到,获得积分10
1秒前
小王发布了新的文献求助10
1秒前
鸭梨发布了新的文献求助10
1秒前
yhuyfuhk完成签到 ,获得积分10
1秒前
呆萌发布了新的文献求助10
1秒前
田様的应助被Mxr采纳,获得10
2秒前
2秒前
董亦菲发布了新的文献求助10
2秒前
猫好好发布了新的文献求助10
2秒前
2秒前
2秒前
3秒前
Jevon完成签到 ,获得积分10
3秒前
3秒前
qiu发布了新的文献求助10
3秒前
3秒前
zisezhaoyan发布了新的文献求助10
3秒前
3秒前
华仔的应助被hhh采纳,获得10
4秒前
4秒前
汉堡包的应助被wsw111采纳,获得10
5秒前
5秒前
5秒前
呆萌完成签到,获得积分10
6秒前
搬砖ing完成签到,获得积分10
6秒前
molihuakai的应助被Lu采纳,获得10
6秒前
无极微光的应助被Shu采纳,获得30
6秒前
Amani_Nakupenda完成签到,获得积分10
6秒前
6秒前
7秒前
hahaha625的应助被古德采纳,获得10
7秒前
标致青雪发布了新的文献求助10
7秒前
lytelope完成签到,获得积分10
7秒前
7秒前
ZJH发布了新的文献求助10
8秒前
汉堡包的应助被杰里西采纳,获得10
8秒前
熊猫海发布了新的文献求助50
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183091
求助须知:如何正确求助?哪些是违规求助? 9572406
关于积分的说明 21825003
捐赠科研通 7779812
什么是DOI,文献DOI怎么找? 3433837
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480046